Caribou Biosciences Statistics Share Statistics Caribou Biosciences has 93.12M
shares outstanding. The number of shares has increased by 2.92%
in one year.
Shares Outstanding 93.12M Shares Change (YoY) 2.92% Shares Change (QoQ) 0% Owned by Institutions (%) 54.23% Shares Floating 84.06M Failed to Deliver (FTD) Shares 12 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.03M, so 4.33% of the outstanding
shares have been sold short.
Short Interest 4.03M Short % of Shares Out 4.33% Short % of Float 4.53% Short Ratio (days to cover) 4.54
Valuation Ratios The PE ratio is -0.96 and the forward
PE ratio is -1.36.
Caribou Biosciences's PEG ratio is
-0.05.
PE Ratio -0.96 Forward PE -1.36 PS Ratio 14.37 Forward PS 7.8 PB Ratio 0.57 P/FCF Ratio -1 PEG Ratio -0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Caribou Biosciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.16,
with a Debt / Equity ratio of 0.1.
Current Ratio 7.16 Quick Ratio 7.16 Debt / Equity 0.1 Debt / EBITDA -0.16 Debt / FCF -0.19 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $67.99K Profits Per Employee $-1.01M Employee Count 147 Asset Turnover 0.03 Inventory Turnover n/a
Taxes Income Tax -9K Effective Tax Rate 0.01%
Stock Price Statistics The stock price has increased by 12.7% in the
last 52 weeks. The beta is 2.54, so Caribou Biosciences's
price volatility has been higher than the market average.
Beta 2.54 52-Week Price Change 12.7% 50-Day Moving Average 1.93 200-Day Moving Average 1.42 Relative Strength Index (RSI) 61.56 Average Volume (20 Days) 1,432,493
Income Statement In the last 12 months, Caribou Biosciences had revenue of 9.99M
and earned -149.1M
in profits. Earnings per share was -1.65.
Revenue 9.99M Gross Profit 6.07M Operating Income -166.62M Net Income -149.1M EBITDA -166.62M EBIT -166.62M Earnings Per Share (EPS) -1.65
Full Income Statement Balance Sheet The company has 16.29M in cash and 26.49M in
debt, giving a net cash position of -10.19M.
Cash & Cash Equivalents 16.29M Total Debt 26.49M Net Cash -10.19M Retained Earnings -448.39M Total Assets 220.9M Working Capital 163.62M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -138.2M
and capital expenditures -4.88M, giving a free cash flow of -143.08M.
Operating Cash Flow -138.2M Capital Expenditures -4.88M Free Cash Flow -143.08M FCF Per Share -1.58
Full Cash Flow Statement Margins Gross margin is 60.71%, with operating and profit margins of -1667.16% and -1491.95%.
Gross Margin 60.71% Operating Margin -1667.16% Pretax Margin -1492.04% Profit Margin -1491.95% EBITDA Margin -1667.16% EBIT Margin -1667.16% FCF Margin -1431.66%
